Description: Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.
Home Page: www.euroapi.com/en
0EAP Technical Analysis
15 Rue Traversiere
Paris,
75012
France
Phone:
33 1 89 20 62 00
Officers
| Name | Title |
|---|---|
| Mr. Ludwig De Mot | CEO, Executive VP & Chief Transformation Officer |
| Mr. Olivier Falut | Chief Financial Officer |
| Mr. David Seignolle | Chief Operating Officer |
| Mr. Kai Rossen | Chief Scientific Officer |
| Sophie Palliez | Head of Investor Relations |
| Ms. Marion Santin | Chief Legal, Compliance, & IP Officer |
| Ute Herzog | Chief Human Resources Officer |
| Ms. Cecile Maupas | Chief CDMO (Contract Development and Manufacturing Organization) Officer |
| Mr. Vincent Touraille | Chief Strategy and M&A Officer |
| Mr. Bruno Laforge | Chief Corporate Affairs Officer |
Exchange: LSE
Country: GB : United Kingdom of Great Britain and Northern Ireland
Currency: Euro (€)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3650 |